textbook of uncommon cancer 4th edition
Textbook of Uncommon Cancer, 4th Edition
$115.00 Original price was: $115.00.$4.99Current price is: $4.99. Add to cart
Sale!

Textbook of Uncommon Cancer, 4th Edition

Original price was: $115.00.Current price is: $4.99.

-96%

Flash Sale: Any ebook for just 4.99 USD only

  • Pay with Any Debit/Credit Card
  • Affordable Prices for Readers
Guaranteed Safe Checkout

The Orphan Malignancies: Textbook of Uncommon Cancer

When an oncologist diagnoses breast or colon cancer, there are thousands of clinical trials and ironclad, universally agreed-upon treatment algorithms to follow. When they diagnose an Adrenocortical Carcinoma or a primary Angiosarcoma of the spleen, there are no algorithms; there is only panic. Textbook of Uncommon Cancer, 4th Edition is the fiercely specialized, absolutely critical master reference detailing exactly how to manage the rarest, most terrifying malignancies on earth. This volume provides the precise oncologic blueprints required when the standard rulebook collapses.

Mastering the Neuroendocrine Tumor (NET)

The core philosophy of this text is managing the biological anomaly. The authors aggressively detail the mechanics of functional tumors. It dictates exactly how to treat a patient whose tumor is not just growing, but is actively secreting massive, lethal amounts of serotonin into their bloodstream, causing catastrophic “carcinoid crisis” (explosive diarrhea, severe flushing, and sudden right-sided heart failure).

Navigating the Unknown Primary

The book provides a masterclass in oncologic detective work. It dictates the exact clinical pathways for the metastatic mystery. It rigorously explores the nightmare scenario where a patient presents with massive tumors in their liver and lungs, but the pathologist cannot find the primary source, detailing the exact immunohistochemical stains and molecular profiling required to blind-fire chemotherapy at an invisible enemy.

Frequently Asked Questions (FAQs)

Does this book cover common diseases like lung, breast, or prostate cancer?
Absolutely not. It is exclusively focused on *rare, orphan, and atypical malignancies* that most oncologists will only see once in their entire career.

Who is the primary audience?
It is the absolute, mandatory definitive reference for Medical Oncologists, Surgical Oncologists, Specialized Pathologists, and Academic Researchers.